Biopharmaceutical product development is all about product knowledge, whether it be writing a regulatory submission, investigating unexpected results, or performing extended characterization.

In this webinar, we will discuss a new strategy to dramatically simplify charge variant characterization. Discover how you can gain multiple pieces of critical information early in process development to assess the impact of cell culture conditions on monoclonal antibody (mAb) quality and production.

• Identify glycation at the intact protein level with the Intabio ZT system
• Maintain separation resolution between icIEF and mass spectrometry
• Implement icIEF/UV-MS during cell culture process development